Pattern of growth of retroperitoneal sarcoma: Do they push or infiltrate adjacent organs? Analysis of a single institution series
2010-01-01 Mussi, C; Bagnoli, P; Coladonato, M; Bertuzzi, A; Secondino, S; Santoro, A; Colombo, P; Navarria, P; Morenghi, E; Quagliuolo, V
The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network
2017-01-01 Cento, V; Barbaliscia, S; Di Maio, Vc; Masetti, C; Minichini, C; Magni, Cf; Micheli, V; Marenco, S; Nicolini, La; Bruzzone, B; Troshina, Y; Baiguera, C; Dentone, C; Calvaruso, V; Paolucci, S; Melis, M; Aragri, M; Bertoli, A; Lenci, I; Landonio, S; Schiavini, M; Sticchi, L; Ruggiero, T; Polilli, E; Messina, V; Pellicelli, A; Boglione, L; Cozzolongo, R; Biolato, M; Morisco, F; Siciliano, M; Parruti, G; Barbarini, G; Craxi, A; Babudieri, S; Puoti, M; Ciancio, A; Rizzardini, G; Coppola, N; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
NS3, NS5A and NS5B Coevolution in Patients Experiencing Virological-Failure with First-Generation Protease Inhibitors
2014-01-01 Di Maio, Vc; Cento, V; Di Paolo, D; De Leonardis, F; Manunta, Af; Micheli, V; Tontodonati, M; Bertoli, A; Antonucci, F; Nosotti, L; Magni, Cf; Vecchiet, J; Mura, Ms; Andreoni, M; Morisco, F; Spaziante, M; Caporaso, N; Parruti, G; Rizzardini, G; Babudieri, S; Taliani, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies
2017-01-01 Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Barbaliscia, S; Francioso, S; Paolucci, S; Melis, M; Verucchi, G; Masetti, C; Coppola, N; Magni, Cf; Micheli, V; Pollicino, T; Ruggiero, T; Landonio, S; Mancon, A; Starace, M; De Leonardis, F; Santopaolo, F; Bertoli, A; Antonucci, Fp; D'Ambrosio, C; Calvaruso, V; Sorbo, Mc; Morisco, F; Pasquazzi, C; Maida, I; Picciotto, A; Di Biagio, A; Bruzzone, B; Sticchi, L; Ghisetti, V; Cozzolongo, R; Romagnoli, D; Boccaccio, V; Grieco, A; Vecchiet, J; D'Ettorre, G; Merli, M; Gaeta, Gb; Ciancio, A; Marinaro, L; Polilli, E; Cacciatore, P; Andreone, P; Barbarini, G; Gulminetti, R; Novati, S; Palitti, Vp; Tarquini, P; Puoti, M; Sangiovanni, V; De Stefano, G; Giorgini, A; Paoloni, M; Caporaso, N; Babudieri, S; Gubertini, G; Bruno, S; Andreoni, M; Pellicelli, A; Parruti, G; Raimondo, G; Baldanti, F; Rizzardini, G; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Thymic-and bone marrow-cellular reservoirs harbor phylogenetically distinct HIV strains and different resistance profiles
2011-01-01 De Luca, F; Bandera, A; Cento, V; Alteri, C; Stazi, F; Bertoli, A; Montano, M; Soria, A; Andreoni, M; Perno, Cf; Gori, A; Silberstein, Fc
PRESENCE OF RESISTANCE ASSOCIATED VARIANTS IN PATIENTS WITH VIROLOGICAL FAILURE TO NEW DIRECT ACTING ANTIVIRALS AND REQUIREMENT OF UNCONVENTIONAL REGIMENS FOR RE-TREATMENT
2016-01-01 Di Maio, Vc; Cento, V; Di Paolo, D; Lenci, I; Aragri, M; Verucchi, G; Melis, M; Bertoli, A; Antonucci, Fp; Francioso, S; Pellicelli, A; Calvaruso, V; Pasquazzi, C; Romagnoli, D; La Rosa, Ky; Campoli, R; Biolato, M; Vecchiet, J; Sorbo, Mc; Morisco, F; Merli, M; Brancaccio, G; Gaeta, Gb; Brillanti, S; Donato, F; Puoti, M; Pisani, V; Grieco, A; Caporaso, N; Paoloni, M; Babudieri, S; Mura, Ms; Crax, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) TREATMENT OF HCV INFECTION IN AN ITALIAN REAL-LIFE URBAN SETTING
2016-01-01 Di Paolo, D; Rossi, P; Lenci, I; Milana, M; Masetti, C; Santopaolo, F; Lionetti, R; D'Offizi, G; Pellicelli, A; Fondacaro, L; Siciliano, M; Tortora, A; Chiesara, F; Moretti, A; Ceccherini-Silberstain, F; Cento, V; Perno, Cf; Angelico, M
NS3, NS5A AND NS5B COEVOLUTION DURING TREATMENT WITH FIRST-GENERATION PROTEASE INHIBITORS
2014-01-01 Di Maio, Vc; Cento, V; Di Paolo, D; Campoli, R; Yu, K; Manunta, A; Micheli, V; Tontodonati, M; De Leonardis, F; Bertoli, A; Antonucci, Fp; Nosotti, L; Sarrecchia, C; Magni, C; Vecchiet, J; Mura, Ms; Andreoni, M; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
HIGH RATES OF HBsAg "a DETERMINANT" VARIABILITY AND IMMUNE ESCAPE MUTATIONS ARE ASSOCIATED WITH HBV REACTIVATION UPON IMMUNOSUPPRESSIVE THERAPY
2013-01-01 Salpini, R; Alteri, C; Cento, V; Ricciardi, A; Maffongelli, G; Pollicita, M; Mirabelli, C; Sarrecchia, C; Sarmati, L; Mastroianni, C; Paoloni, M; Angelico, M; Andreoni, M; Perno, Cf; Svicher, V
CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION AND PERSISTENCE OF RESISTANT ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING
2015-01-01 Di Maio, Vc; Armenia, D; Bellocchi, Mc; Di Paolo, D; Cento, V; Tontodonati, M; Micheli, V; Carioti, L; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; De Maria, A; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Taliani, G; Andreoni, M; Rizzardini, G; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV QUANTIFICATION WITHIN BLOOD AND LIVER SAMPLES (TUMORAL AND NON TUMORAL TISSUES) OF HCC/TRANSPLANTED PATIENTS
2016-01-01 Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
ROLE OF CIRCULATING SURVIVIN-IGM IMMUNOCOMPLEXES IN PATIENTS AFFECTED BY LIVER DISEASES
2010-01-01 Sorrentino, R; Ettorre, Gm; Bellis, L; Antenucci, A; Santoro, R; Vennarecci, G; Svicher, V; Cento, V; Beneduce, L; Biasiolo, A; Pontisso, P; Puoti, C; Pierimarchi, P; Garaci, E; Rasi, G; Matteucci, C
SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT
2015-01-01 Lenci, I; Cento, V; Rendina, M; Donato, Mf; Milana, M; Sforza, D; Manuelli, M; Aragri, M; Di Maio, Vc; Abedrabbo, A; Castellaneta, A; Malinverno, F; Monico, S; Ponti, Ml; Canu, R; Ganga, R; Alfieri, R; Milanesi, L; Di Leo, A; Tisone, G; Perno, Cf; Ceccherini-Silberstein, F; Colombo, M; Angelico, M
HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life
2017-01-01 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Paolucci, S; Troshina, Y; Biliotti, E; Milana, M; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Di Maio, Vc; Aragri, M; Pecchioli, A; Bertoli, A; Antonucci, Fp; Sarmati, L; Sarrecchia, C; Macera, M; Coppola, N; Danieli, E; Romagnoli, D; Pellicelli, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Novati, S; Siciliano, M; Messina, V; Claar, E; Baldanti, F; Pasquazzi, C; Ciancio, A; Puoti, M; Ghisetti, V; Andreoni, M; Taliani, G; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT
2016-01-01 Di Maio, Vc; Cento, V; Di Paolo, D; Lenci, I; Aragri, M; Verucchi, G; Melis, M; Bertoli, A; Antonucci, Fp; Francioso, S; Pellicelli, A; Calvaruso, V; Pasquazzi, C; Romagnoli, D; Biolato, M; Vecchiet, J; Morisco, F; Merli, M; Gaeta, Gb; Brillanti, S; Donato, F; Puoti, M; Pisani, V; Paoloni, M; Babudieri, S; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis
2009-01-01 Ceccherini-Silberstein, F; Armenia, D; D'Arrigo, R; Vandenbroucke, I; Van Marck, H; Fabeni, L; Cento, V; Van Baelen, K; Rizzardini, G; Lo Caputo, S; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf
THE GENOTYPIC FALSE POSITIVE RATE DETERMINED BY POPULATION V3-SEQUENCING CAN PREDICT THE BURDEN OF X4 QUASISPECIES DETECTED BY PYROSEQUENCING
2011-01-01 Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, Mm; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, Ar; Andreoni, M; Perno, Cf; Capobianchi, Mr; Ceccherini-Silberstein, F
EARLY-PHASE HCV KINETICS AND ROLE OF PRE-EXISTING RESISTANCE IN CIRRHOTIC OR INTERFERON-INSENSITIVE PATIENTS ON DACLATASVIR PLUS ASUNAPREVIR
2015-01-01 Cento, V; Calvaruso, V; Marenco, S; Alfieri, R; Aragri, M; Antonucci, Fp; Di Maio, Vc; Petta, S; Mazzola, A; Milanesi, L; Picciotto, A; Ceccherini-Silberstein, F; Craxi, A; Perno, Cf
DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV RNA QUANTIFICATION WITHIN TUMORAL AND NON TUMORAL LIVER TISSUES IN HCC/TRANSPLANTED PATIENTS
2016-01-01 Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
HCV GENOTYPES HAVE DIFFERENT GENETIC BARRIERS IN THE GENERATION OF RESISTANCE MUTATIONS TO PROTEASE INHIBITORS IN ADVANCED CLINICAL DEVELOPMENT
2011-01-01 Cento, V; Mirabelli, C; Mercurio, F; Salpini, R; Dimonte, S; Svicher, V; Bertoli, A; Ciotti, M; Almerighi, C; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pattern of growth of retroperitoneal sarcoma: Do they push or infiltrate adjacent organs? Analysis of a single institution series | 1-gen-2010 | Mussi, C; Bagnoli, P; Coladonato, M; Bertuzzi, A; Secondino, S; Santoro, A; Colombo, P; Navarria, P; Morenghi, E; Quagliuolo, V | |
| The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network | 1-gen-2017 | Cento, V; Barbaliscia, S; Di Maio, Vc; Masetti, C; Minichini, C; Magni, Cf; Micheli, V; Marenco, S; Nicolini, La; Bruzzone, B; Troshina, Y; Baiguera, C; Dentone, C; Calvaruso, V; Paolucci, S; Melis, M; Aragri, M; Bertoli, A; Lenci, I; Landonio, S; Schiavini, M; Sticchi, L; Ruggiero, T; Polilli, E; Messina, V; Pellicelli, A; Boglione, L; Cozzolongo, R; Biolato, M; Morisco, F; Siciliano, M; Parruti, G; Barbarini, G; Craxi, A; Babudieri, S; Puoti, M; Ciancio, A; Rizzardini, G; Coppola, N; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| NS3, NS5A and NS5B Coevolution in Patients Experiencing Virological-Failure with First-Generation Protease Inhibitors | 1-gen-2014 | Di Maio, Vc; Cento, V; Di Paolo, D; De Leonardis, F; Manunta, Af; Micheli, V; Tontodonati, M; Bertoli, A; Antonucci, F; Nosotti, L; Magni, Cf; Vecchiet, J; Mura, Ms; Andreoni, M; Morisco, F; Spaziante, M; Caporaso, N; Parruti, G; Rizzardini, G; Babudieri, S; Taliani, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies | 1-gen-2017 | Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Barbaliscia, S; Francioso, S; Paolucci, S; Melis, M; Verucchi, G; Masetti, C; Coppola, N; Magni, Cf; Micheli, V; Pollicino, T; Ruggiero, T; Landonio, S; Mancon, A; Starace, M; De Leonardis, F; Santopaolo, F; Bertoli, A; Antonucci, Fp; D'Ambrosio, C; Calvaruso, V; Sorbo, Mc; Morisco, F; Pasquazzi, C; Maida, I; Picciotto, A; Di Biagio, A; Bruzzone, B; Sticchi, L; Ghisetti, V; Cozzolongo, R; Romagnoli, D; Boccaccio, V; Grieco, A; Vecchiet, J; D'Ettorre, G; Merli, M; Gaeta, Gb; Ciancio, A; Marinaro, L; Polilli, E; Cacciatore, P; Andreone, P; Barbarini, G; Gulminetti, R; Novati, S; Palitti, Vp; Tarquini, P; Puoti, M; Sangiovanni, V; De Stefano, G; Giorgini, A; Paoloni, M; Caporaso, N; Babudieri, S; Gubertini, G; Bruno, S; Andreoni, M; Pellicelli, A; Parruti, G; Raimondo, G; Baldanti, F; Rizzardini, G; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| Thymic-and bone marrow-cellular reservoirs harbor phylogenetically distinct HIV strains and different resistance profiles | 1-gen-2011 | De Luca, F; Bandera, A; Cento, V; Alteri, C; Stazi, F; Bertoli, A; Montano, M; Soria, A; Andreoni, M; Perno, Cf; Gori, A; Silberstein, Fc | |
| PRESENCE OF RESISTANCE ASSOCIATED VARIANTS IN PATIENTS WITH VIROLOGICAL FAILURE TO NEW DIRECT ACTING ANTIVIRALS AND REQUIREMENT OF UNCONVENTIONAL REGIMENS FOR RE-TREATMENT | 1-gen-2016 | Di Maio, Vc; Cento, V; Di Paolo, D; Lenci, I; Aragri, M; Verucchi, G; Melis, M; Bertoli, A; Antonucci, Fp; Francioso, S; Pellicelli, A; Calvaruso, V; Pasquazzi, C; Romagnoli, D; La Rosa, Ky; Campoli, R; Biolato, M; Vecchiet, J; Sorbo, Mc; Morisco, F; Merli, M; Brancaccio, G; Gaeta, Gb; Brillanti, S; Donato, F; Puoti, M; Pisani, V; Grieco, A; Caporaso, N; Paoloni, M; Babudieri, S; Mura, Ms; Crax, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) TREATMENT OF HCV INFECTION IN AN ITALIAN REAL-LIFE URBAN SETTING | 1-gen-2016 | Di Paolo, D; Rossi, P; Lenci, I; Milana, M; Masetti, C; Santopaolo, F; Lionetti, R; D'Offizi, G; Pellicelli, A; Fondacaro, L; Siciliano, M; Tortora, A; Chiesara, F; Moretti, A; Ceccherini-Silberstain, F; Cento, V; Perno, Cf; Angelico, M | |
| NS3, NS5A AND NS5B COEVOLUTION DURING TREATMENT WITH FIRST-GENERATION PROTEASE INHIBITORS | 1-gen-2014 | Di Maio, Vc; Cento, V; Di Paolo, D; Campoli, R; Yu, K; Manunta, A; Micheli, V; Tontodonati, M; De Leonardis, F; Bertoli, A; Antonucci, Fp; Nosotti, L; Sarrecchia, C; Magni, C; Vecchiet, J; Mura, Ms; Andreoni, M; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| HIGH RATES OF HBsAg "a DETERMINANT" VARIABILITY AND IMMUNE ESCAPE MUTATIONS ARE ASSOCIATED WITH HBV REACTIVATION UPON IMMUNOSUPPRESSIVE THERAPY | 1-gen-2013 | Salpini, R; Alteri, C; Cento, V; Ricciardi, A; Maffongelli, G; Pollicita, M; Mirabelli, C; Sarrecchia, C; Sarmati, L; Mastroianni, C; Paoloni, M; Angelico, M; Andreoni, M; Perno, Cf; Svicher, V | |
| CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION AND PERSISTENCE OF RESISTANT ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING | 1-gen-2015 | Di Maio, Vc; Armenia, D; Bellocchi, Mc; Di Paolo, D; Cento, V; Tontodonati, M; Micheli, V; Carioti, L; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; De Maria, A; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Taliani, G; Andreoni, M; Rizzardini, G; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV QUANTIFICATION WITHIN BLOOD AND LIVER SAMPLES (TUMORAL AND NON TUMORAL TISSUES) OF HCC/TRANSPLANTED PATIENTS | 1-gen-2016 | Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| ROLE OF CIRCULATING SURVIVIN-IGM IMMUNOCOMPLEXES IN PATIENTS AFFECTED BY LIVER DISEASES | 1-gen-2010 | Sorrentino, R; Ettorre, Gm; Bellis, L; Antenucci, A; Santoro, R; Vennarecci, G; Svicher, V; Cento, V; Beneduce, L; Biasiolo, A; Pontisso, P; Puoti, C; Pierimarchi, P; Garaci, E; Rasi, G; Matteucci, C | |
| SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT | 1-gen-2015 | Lenci, I; Cento, V; Rendina, M; Donato, Mf; Milana, M; Sforza, D; Manuelli, M; Aragri, M; Di Maio, Vc; Abedrabbo, A; Castellaneta, A; Malinverno, F; Monico, S; Ponti, Ml; Canu, R; Ganga, R; Alfieri, R; Milanesi, L; Di Leo, A; Tisone, G; Perno, Cf; Ceccherini-Silberstein, F; Colombo, M; Angelico, M | |
| HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life | 1-gen-2017 | Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Paolucci, S; Troshina, Y; Biliotti, E; Milana, M; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Di Maio, Vc; Aragri, M; Pecchioli, A; Bertoli, A; Antonucci, Fp; Sarmati, L; Sarrecchia, C; Macera, M; Coppola, N; Danieli, E; Romagnoli, D; Pellicelli, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Novati, S; Siciliano, M; Messina, V; Claar, E; Baldanti, F; Pasquazzi, C; Ciancio, A; Puoti, M; Ghisetti, V; Andreoni, M; Taliani, G; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT | 1-gen-2016 | Di Maio, Vc; Cento, V; Di Paolo, D; Lenci, I; Aragri, M; Verucchi, G; Melis, M; Bertoli, A; Antonucci, Fp; Francioso, S; Pellicelli, A; Calvaruso, V; Pasquazzi, C; Romagnoli, D; Biolato, M; Vecchiet, J; Morisco, F; Merli, M; Gaeta, Gb; Brillanti, S; Donato, F; Puoti, M; Pisani, V; Paoloni, M; Babudieri, S; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis | 1-gen-2009 | Ceccherini-Silberstein, F; Armenia, D; D'Arrigo, R; Vandenbroucke, I; Van Marck, H; Fabeni, L; Cento, V; Van Baelen, K; Rizzardini, G; Lo Caputo, S; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf | |
| THE GENOTYPIC FALSE POSITIVE RATE DETERMINED BY POPULATION V3-SEQUENCING CAN PREDICT THE BURDEN OF X4 QUASISPECIES DETECTED BY PYROSEQUENCING | 1-gen-2011 | Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, Mm; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, Ar; Andreoni, M; Perno, Cf; Capobianchi, Mr; Ceccherini-Silberstein, F | |
| EARLY-PHASE HCV KINETICS AND ROLE OF PRE-EXISTING RESISTANCE IN CIRRHOTIC OR INTERFERON-INSENSITIVE PATIENTS ON DACLATASVIR PLUS ASUNAPREVIR | 1-gen-2015 | Cento, V; Calvaruso, V; Marenco, S; Alfieri, R; Aragri, M; Antonucci, Fp; Di Maio, Vc; Petta, S; Mazzola, A; Milanesi, L; Picciotto, A; Ceccherini-Silberstein, F; Craxi, A; Perno, Cf | |
| DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV RNA QUANTIFICATION WITHIN TUMORAL AND NON TUMORAL LIVER TISSUES IN HCC/TRANSPLANTED PATIENTS | 1-gen-2016 | Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| HCV GENOTYPES HAVE DIFFERENT GENETIC BARRIERS IN THE GENERATION OF RESISTANCE MUTATIONS TO PROTEASE INHIBITORS IN ADVANCED CLINICAL DEVELOPMENT | 1-gen-2011 | Cento, V; Mirabelli, C; Mercurio, F; Salpini, R; Dimonte, S; Svicher, V; Bertoli, A; Ciotti, M; Almerighi, C; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2016
Data di pubblicazione
- 2020 - 2025102
- 2010 - 20191268
- 2000 - 2009534
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY121
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE96
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY58
- ANNALS OF ONCOLOGY55
- JOURNAL OF CLINICAL ONCOLOGY44
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng732
- ita24
- und6
Accesso al fulltext
- no fulltext1963
- reserved51
- open2